Organisation paid for research Program year 2025 Source: CMS Open Payments

Advanced Heart Care, LLC .

Neither a doctor nor a teaching hospital

Research payments

$254,234

9 payments

Through program year 2025, Advanced Heart Care, LLC . is reported as receiving $254,234 in research payments, across 9 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$133,460	2
2024	Research	$71,858	2
2023	Research	$48,916	5

Breakdown

Who paid Research payments · program years 2023–2025

Novartis Pharmaceuticals Corporation $254,234 9 payments

Studies the money was for Research payments · program years 2023–2025

Evaluation of Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention (V-INTERVENTION) $116,593 1 payment
A Randomized, Controlled, Multicenter, Open-Label Trial Comparing A Post-Discharge Care Pathway Involving Aggressive LDL-C Management With Inclisiran With Usual Care in Patients With A Recent Acute Coronary Syndrome $82,002 3 payments
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) $50,590 4 payments
An Open-Label Extension Trial of the Phase III Lipid-Lowering Trials to Assess the Effect of Long Term Dosing of Inclisiran Given As Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated LDL-C $5,050 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.